CytomX Therapeutics, Inc. (CTMX)
4.335
+0.12
(+2.73%)
USD |
NASDAQ |
Mar 26, 14:31
CytomX Therapeutics Free Cash Flow : -75.81M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Rigel Pharmaceuticals, Inc. | 75.66M |
| REGENXBIO, Inc. | -126.38M |
| Ovid Therapeutics, Inc. | -38.33M |
| Olema Pharmaceuticals, Inc. | -146.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.24M |
| Cash from Investing (Quarterly) | -14.42M |
| Cash from Financing (Quarterly) | 16.64M |
| Free Cash Flow Per Share (Quarterly) | -0.1378 |
| Free Cash Flow to Equity (Quarterly) | -22.09M |
| Free Cash Flow to Firm (Quarterly) | -23.44M |
| Free Cash Flow Yield | -12.69% |